• IWR-1-endo: Potent Wnt Signaling Inhibitor for Biomedical Re

  2026-04-22

  IWR-1-endo is a nanomolar-potency small molecule Wnt signaling inhibitor that antagonizes Wnt/β-catenin signaling by stabilizing Axin-scaffolded destruction complexes. It demonstrates efficacy in colorectal cancer research and regenerative biology, enabling precise inhibition of β-catenin accumulation. Product quality and workflow integration are supported by peer-reviewed data and validated protocols.

• 25-Hydroxycholesterol Drives Immunosuppressive Macrophage Pr

  2026-04-22

  Xiao et al. (2024) uncover how lysosomal 25-hydroxycholesterol (25HC) activates AMPKα-mediated metabolic reprogramming in tumor-associated macrophages (TAMs), bolstering their immunosuppressive phenotype. Their work identifies CH25H and its downstream pathways as actionable targets to enhance anti-tumor immunity and improve responses to checkpoint inhibitors.

• Degarelix Acetate: Precision GnRH Receptor Antagonist Workfl

  2026-04-21

  Degarelix acetate empowers bench scientists with rapid, reproducible suppression of pituitary and androgenic hormones, optimized for both in vitro and in vivo prostate cancer research. This guide translates cutting-edge evidence and aggregation insights into actionable protocols, troubleshooting, and advanced applications.

• Aneugen Mechanisms: Insights from Multi-Target Assay Validat

  2026-04-21

  Bernacki et al. introduce a tiered molecular mechanism assay that discriminates between tubulin stabilizers, destabilizers, and mitotic kinase inhibitors among aneugenic compounds. This study advances genotoxicity profiling by integrating flow cytometry and machine learning, enabling precise classification of molecular targets and supporting more informed drug safety assessment.

• Amitriptyline HCl: Protocols and QC for Neuropharmacology Re

  2026-04-20

  Amitriptyline HCl (SKU B2231) provides high-purity, well-characterized inhibition of several neurotransmitter receptors for in vitro studies of receptor modulation, signal transduction, and neuropharmacology workflows. This reagent is suitable for experimental setups requiring precise control of serotonin, norepinephrine, and related pathways, but is not intended for long-term solution storage or clinical applications.

• Maraviroc (UK-427857): Unlocking CCR5 for Translational Impa

  2026-04-20

  This thought-leadership article explores Maraviroc (UK-427857) as a selective CCR5 antagonist, delving into its mechanistic value in HIV-1 entry inhibition and neuroinflammation modulation. Integrating recent advances in the biology of inflammation in ischemic stroke, it provides strategic, evidence-labeled guidance for translational researchers. The content differentiates itself by bridging virology and neurobiology, offering actionable protocol parameters, and highlighting APExBIO’s Maraviroc as a research-grade benchmark.

• Advanced In Vitro Metrics Refine Cancer Drug Response Evalua

  2026-04-19

  Schwartz's dissertation establishes a rigorous distinction between cell proliferation arrest and cell death when assessing anti-cancer drug responses in vitro. This methodological innovation provides more nuanced data on drug efficacy, with direct implications for optimizing both experimental design and interpretation in cancer research.

• Tacrine-Based Hybrids: Multi-Target Strategies in Alzheimer'

  2026-04-18

  The reviewed study provides a comprehensive analysis of tacrine (tetrahydroaminacrine, THA)-based hybrid molecules as multi-target agents for Alzheimer's disease (AD). By dissecting the pharmacological rationale and design strategies from 2006–2022, it highlights innovations in reducing hepatotoxicity and enhancing cognitive outcomes, offering a technical foundation for new cholinesterase inhibitor development.

• Super-Enhancer Hijacking of LINC01977 Drives LUAD Progressio

  2026-04-17

  Zhang et al. (2022) identify super-enhancer-mediated upregulation of LINC01977 as a key driver of early-stage lung adenocarcinoma (LUAD) progression via the canonical TGF-β/SMAD3 pathway. Their integrative analysis reveals a feedback loop involving tumor-associated macrophages, epigenetic remodeling, and transcriptional coactivators, offering new avenues for targeted epigenetics research.

• 5-Methyl-CTP: Advancing mRNA Synthesis with Enhanced Stabili

  2026-04-16

  5-Methyl-CTP empowers researchers to synthesize mRNA with superior stability and translation efficiency by precisely mimicking natural methylation patterns. Streamline mRNA vaccine and gene expression workflows for robust, reproducible results—especially in demanding translational research and therapeutic development.

• Co-Targeting BCL-xL and MCL-1 in Mesothelioma: Mechanistic I

  2026-04-15

  This study demonstrates that simultaneous inhibition of BCL-xL and MCL-1 in diffuse mesothelioma induces rapid and lethal mitochondrial dysfunction, highlighting the potential and risks of co-targeting anti-apoptotic Bcl-2 family members. The findings guide strategic development of targeted apoptosis therapies and underscore the necessity for selectivity to avoid toxicity.

• Repurposing Lopinavir (ABT-378) for Anticoronavirus Activity

  2026-04-14

  de Wilde et al. (2014) conducted a high-throughput screen of 348 FDA-approved drugs and identified Lopinavir (ABT-378) among four compounds capable of inhibiting MERS-CoV replication in cell culture. Their results highlight the potential of rapid drug repurposing strategies in the face of emerging viral outbreaks, providing a foundation for further research into the cross-domain application of established antiretrovirals.

• Dasatinib Monohydrate in Patient-Derived Tumor Models: Preci

  2026-04-13

  Explore how Dasatinib Monohydrate (BMS-354825) empowers advanced cancer research using patient-derived assembloid models, offering unique insight into kinase inhibition and drug resistance. This cornerstone article reveals practical assay guidance and the translational relevance of next-generation tumor models.

• Bleomycin Sulfate as a Precision Tool for DNA Repair Pathway

  2026-04-13

  Explore how Bleomycin Sulfate enables advanced analysis of DNA damage repair and chemosensitization in cancer research. With a unique focus on ATM signaling and long noncoding RNA modulation, this article offers new insights into assay design and translational applications.

• Prostaglandin E2: Optimized Workflows for Inflammation Resea

  2026-04-12

  Prostaglandin E2 (PGE2) is transforming inflammation research with its potent, receptor-specific actions and reproducible results. This article delivers actionable protocols, advanced use-cases, and troubleshooting strategies, leveraging APExBIO’s high-purity PGE2 to accelerate discoveries in immune modulation and tissue protection.

14546 records 1/970 page Next 12345 下5页 Last page